Methods of diagnosing and treating hepatocellular carcinoma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10925884
APP PUB NO 20180296575A1
SERIAL NO

15953526

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein is a novel use of HSD3B1 in disease diagnosis. According to embodiments of the present disclosure, the mRNA or protein level of HSD3B1 may serve as an indicator for diagnosing hepatocellular carcinoma. Also disclosed herein are methods for treating hepatocellular carcinoma by use of HSD3B1 inhibitor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MACKAY MEMORIAL HOSPITAL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lin, Jiunn-Chang Taipei, TW 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 23, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 23, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 23, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00